PL2825558T3
Combination therapy for the treatment of ovarian cancer
Abstract
This record has no abstract on file.
Term
6.5 yearsto projected expiry
Projected expiry 11 March 2033, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
3 sheets
Sheet 1 Sheet 2 Sheet 3
49 members in 32 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 201261610128 | United States of America | P | |
| 201261610128 | United States of America | P | |
| 201261653598 | United States of America | P | |
| 201261653598 | United States of America | P | |
| 201261672987 | United States of America | P | |
| 201261672987 | United States of America | P | |
| 13708435 | European Patent Office (EPO) | A | |
| 2013054818 | European Patent Office (EPO) | W | |
| 2013054818 | European Patent Office (EPO) | W | |
| EP20130708435 | – | – | – |
| US201261610128P | – | – | – |
| US201261653598P | – | – | – |
| US201261672987P | – | – | – |
| WO2013EP54818 | – | – | – |
Members49
| Document | Office | Kind | |
|---|---|---|---|
| CA2860941A1 | Canada | A1 | |
| CA3056813A1 | Canada | A1 | |
| WO2013135602A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW201343178A | Taiwan Province of China | A | |
| WO2013135602A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2013231410A1 | Australia | A1 | |
| CO7000770A2 | Colombia | A2 | |
| MX2014010591A | Mexico | A | |
| CR20140400A | Costa Rica | A | |
| PH12014501543A1 | Philippines | A1 | |
| SG11201404417PA | Singapore | A | |
| AR090313A1 | Argentina | A1 | |
| PE20141909A1 | Peru | A1 | |
| MA35927B1 | Morocco | B1 | |
| KR20140138691A | Republic of Korea | A | |
| EP2825558A2 | European Patent Office (EPO) | A2 | |
| CN104334577A | China | A | |
| EA201400996A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2015098988A1 | United States of America | A1 | |
| JP2015511593A | Japan | A | |
| ZA201404843B | South Africa | B | |
| HK1202122A1 | Hong Kong, China | A1 | |
| US2016289317A1 | United States of America | A1 | |
| BR112014018964A8 | Brazil | A8 | |
| AU2013231410B2 | Australia | B2 | |
| AU2017258927A1 | Australia | A1 | |
| JP2018193380A | Japan | A | |
| IL234174B | Israel | B | |
| IL263781A | Israel | A | |
| EP2825558B1 | European Patent Office (EPO) | B1 | |
| MX365139B | Mexico | B | |
| PT2825558T | Portugal | T | |
| DK2825558T3 | Denmark | T3 | |
| LT2825558T | Lithuania | T | |
| JP6563197B2 | Japan | B2 | |
| RS58964B1 | Serbia | B1 | |
| SI2825558T1 | Slovenia | T1 | |
| EP3553083A1 | European Patent Office (EPO) | A1 | |
| HRP20191248T1 | Croatia | T1 | |
| CA2860941C | Canada | C | |
| PL2825558T3This record | Poland | T3 | |
| ES2736030T3 | Spain | T3 | |
| HUE045445T2 | Hungary | T2 | |
| JP6640288B2 | Japan | B2 | |
| KR102082363B1 | Republic of Korea | B1 | |
| BR112014018964A2 | Brazil | A2 | |
| CY1121821T1 | Cyprus | T1 | |
| US11384142B2 | United States of America | B2 | |
| KR102082363B9 | Republic of Korea | B9 |
Numbers
- Publication, DOCDB
- 2825558
- Publication, EPODOC
- PL2825558T
- Application
- 708435
- Application, DOCDB
- 13708435
- Application, EPODOC
- PL20130708435T
Titles2
- English
- COMBINATION THERAPY FOR THE TREATMENT OF OVARIAN CANCER
- Polish
- Terapia skojarzona w leczeniu raka jajnika
Classification
- CPC, 18
- C07K16/22
- A61K31/337
- A61K31/4745
- A61K2039/507
- A61K31/704
- A61K45/06
- A61K39/3955
- A61K2039/505
- G06Q30/0241
- A61K2039/54
- A61K2039/545
- A61K2039/55
- A61P15/08
- A61P35/00
- G06Q90/00
- A61P43/00
- A61K9/1271
- C07K2317/56
- IPC, 2
- C07K16 22
- A61K31 337